Brief: MGC Pharmaceuticals Posts HY Net Loss Attributable A$7.1 Million Versus Loss A$10.9 Million
Feb 29 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* HY NET LOSS ATTRIBUTABLE A$7.1 MILLION VERSUS LOSS A$10.9
MILLION
Source text for Eikon: ID:nASX6jVlS0
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program